Mundipharma: Asthma trials

The registry lists 16 Asthma studies with Mundipharma as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 2 2Phase 3 9Phase 4 3No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Efficiency Control of Fluticasone/Formoterol K-haler (Medium Strength) vs ICS/LABA (High Strength) in Asthma PatientsWithdrawnNCT04271839Phase 4
• Efficacy and Safety of Flutiform K-haler in Patients With Uncontrolled Asthma Following Mid-dose ICS/LABA DPI TherapyTerminatedNCT04124510Phase 3
• Efficacy of FLUTIFORM ® vs Seretide® in Moderate to Severe Persistent Asthma in Subjects Aged ≥12 YearsStatus unknownNCT03387241Phase 3
• Flutiform in Treatment of Patients With Asthma in Daily Clinical Practice.WithdrawnNCT02811315
• A Study to Evaluate the Effect of Fluticasone/Formoterol Breath Actuated Inhaler (BAI) or Relvar® Ellipta® DPI on Ventilation Heterogeneity in AsthmaCompletedNCT02753712Phase 3
• Small Airway Function of Fluticasone/Formoterol (Flutiform®) and Fluticasone/SalmeterolTerminatedNCT02491970Phase 4
• Knemometry Study to Compare the Systemic Safety of Flutiform pMDI, Fluticasone pMDI and Beclometasone Autohaler in Paediatric Subjects Aged 5 to Less Than 12 Years.CompletedNCT02063139Phase 2
• A Study Assessing Patient Handling of Flutiform® Breath-Actuated Inhaler (BAI) and Flutiform® Pressurised Metered Dose Inhaler (pMDI)CompletedNCT01739387
• Comparison of Flutiform, Fluticasone and Seretide in Treatment of Moderate to Severe Asthma in Paediatric PatientsCompletedNCT01511367Phase 3
• Mannitol Challenge Test in Adult Asthma Patients With Fixed Dose CombinationsCompletedNCT01449123Phase 4
• Assessment of the Efficacy and Safety of FlutiForm® pMDI 125/5 µg (2 Puffs Bid) Versus Symbicort® Turbohaler® 200/6 µg (2 Puffs Bid) in Adolescent and Adult Subjects With Moderate to Severe Persistent, Reversible AsthmaCompletedNCT01099722Phase 3
• Study to Assess Airway Inflammation Effects of FlutiForm® pMDI Low and High Dose in Adults With Mild to Moderate AsthmaCompletedNCT00995800Phase 2
• Study of FlutiForm® Versus Fluticasone Plus Formoterol in Adult Subjects With Severe AsthmaCompletedNCT00734318Phase 3
• An Open, Randomised, Parallel Group Multicentre Study to Compare the Efficacy and Safety of Flutiform® pMDI vs Fluticasone pMDI Plus Formoterol DPI in Adolescent and Adult Subjects With Mild to Moderate-severe Persistent, Reversible AsthmaCompletedNCT00563056Phase 3
• Efficacy and Safety of Flutiform® pMDI in Adult Patients With Mild to Moderate-severe Reversible AsthmaCompletedNCT00476073Phase 3
• Study of FLUTIFORM® VS Seretide® in Paediatric Subjects With AsthmaCompletedNCT00475813Phase 3